CervoMed (CRVO) Times Interest Earned (2010 - 2026)
CervoMed (CRVO) posted Times Interest Earned of -$24727.2 for Q1 2026, down 30.95% sequentially from -$18883.1 in Q3 2025, and down 267.91% YoY from $14726.6 in Q1 2025.
CervoMed (CRVO) Times Interest Earned (2010 - 2026) Analysis & Trends
CervoMed has reported Times Interest Earned for 17 years, with the latest figure at -$24727.2 in Q1 2026.
- Quarterly Times Interest Earned fell 267.91% year-over-year to -$24727.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$94824.7 (down 257.37% YoY) and the FY2024 annual result came in at -$6547.1, down 29928.41% from the prior year.
- Times Interest Earned eased to -$24727.2 in Q1 2026 per CRVO's latest filing, from -$18883.1 in the prior quarter.
- Over five years, Times Interest Earned peaked at $60.91 in Q4 2022 and troughed at -$24727.2 in Q1 2026.
- A 5-year average of -$4661.1 and a median of -$279.06 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned jumped 36529.78% in 2022, then plunged 37473.65% in 2024.
- Over 5 years, Times Interest Earned stood at $60.91 in 2022, then plunged by 111.36% to -$6.92 in 2023, then tumbled by 37473.65% to -$2600.9 in 2024, then tumbled by 626.03% to -$18883.1 in 2025, then sank by 30.95% to -$24727.2 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$24727.2, -$18883.1, and -$1295.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247,353.74 |
| Mar 31, 2026 | -24,727.21 |
| Sep 30, 2025 | -18,883.10 |
| Jun 30, 2025 | -1,295.02 |
| Mar 31, 2025 | -6,721.02 |
| Dec 31, 2024 | -2,600.87 |
| Sep 30, 2024 | -10,337.69 |
| Jun 30, 2024 | -130.18 |
| Dec 31, 2023 | -6.92 |
| Jun 30, 2023 | -34.54 |
| Mar 31, 2023 | -427.94 |
| Dec 31, 2022 | 60.91 |
| Sep 30, 2022 | -10.40 |
| Jun 30, 2022 | -49.02 |
| Mar 31, 2022 | -91.72 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -264.46 |
| Jun 30, 2021 | -17.48 |
| Mar 31, 2021 | -151.11 |
| Dec 31, 2020 | -0.27 |